Author: healthadmin

Healthcare faces staffing shortages, rising costs, and complex care needs. Explore how telemedicine, wearables, and AI diagnostics are driving health tech trends for 2026, essential for founders, engineers, and IT pros.

Researchers tracked more than 13 million days of real-world activity to reveal how step counts can counteract the harms of sitting for too long, while warning that too much sitting still poses lasting risks to the heart. Study: All of Us research program shows daily step count offsets the risk of sedentary behavior. Image credit: Jacek Chabraszewski/Shutterstock.com More than one in three adults spends long periods of time sedentary, which is associated with a higher risk of chronic disease and early death. research in nature communications We found that while not foolproof against certain heart conditions, increasing the number of…

Recent studies have shown evidence that intense hunger after cannabis use is a neural response that increases the desire to eat, regardless of the body’s actual caloric needs. These findings suggest that cannabis may serve as a medical tool to stimulate appetite in people experiencing weight loss due to chronic illness. This research Proceedings of the National Academy of Sciences. Cannabis is a plant that contains psychoactive compounds, specifically tetrahydrocannabinol (THC). When a person inhales or ingests cannabis, THC interacts with the body’s endocannabinoid system, a complex network of receptors that helps regulate mood, memory, pain, and appetite. Although intense…

Takeda Pharmaceutical has ended its neurodegenerative disease collaboration with Denali Therapeutics. Merck & Company and Zhifei have eliminated minimum purchase requirements in vaccine distribution agreements. Shionogi & Co. has secured funding from the US government to increase the domestic supply of antibiotics. moreover. 1. Takeda terminates partnership with Denali, returns dementia assets during restructuring Takeda has returned its dementia candidate, coded DNL593, to Denali Therapeutics, effectively ending a collaboration that began in 2018 to jointly develop up to three new drugs for neurodegenerative diseases. According to a filing with Denali Securities, Takeda is in turnaround mode and made this decision…

In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increased risk of lung cancer, mesothelioma, or laryngeal cancer. The survey results are Journal of Thoracic Oncology, Official journal of the International Association for Lung Cancer Research. Access the full study here: https://www.jto.org/article/S1556-0864(26)00163-2/. Evidence suggests a potential link between occupational talc exposure and increased risk of lung cancer and mesothelioma when talc is contaminated with asbestos, a known carcinogen. However, the findings regarding uncontaminated talc were inconclusive. To address this issue, researchers led by Paolo Boffetta…

Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is currently accepting enrollment for a clinical trial for patients with high-grade neuroendocrine tumors. High-grade neuroendocrine cancer is a complex and progressive disease, but little medical progress has been made, in part because its rarity has constrained research investment. Patients have few options other than conventional chemotherapy. The new trial, led by Dr. Aman Chauhan, leader of Sylvester University’s neuroendocrine tumor program, offers a new approach. Patients are injected directly into their tumors with a combination of immunotherapy drugs and tumor-destroying “oncolytic” viruses. Tumors of any…

Revvity, Inc. announced that its Revvity Signals Software business is launching Signals BioDesign™, a cloud-native molecular cloning solution that streamlines biopharmaceutical research workflows. Built for biotech and pharmaceutical R&D teams, this platform simplifies complex cloning processes and enables scalable collaborative development in a unified digital environment. Combining essential cloning techniques with enterprise-grade collaboration addresses the limitations of desktop tools and overly complex platforms. Signals BioDesign products provide a complete solution for designing therapeutic constructs across core cloning workflows such as Golden Gate, Gibson assembly, and restriction/ligation, as well as primer design, Sanger sequence analysis, and protein translation in one easy-to-use…

Recent research published in Personality and Social Psychology Bulletin When climax occurs infrequently, both women and men suggest that it is less important for women to experience climax. This psychological adjustment tends to protect a person’s self-esteem and relationship satisfaction in the short term. Over time, this mental change likely contributes to the continuing orgasm gap, a consistent difference in how often heterosexual men and women experience climax during sex with their partners. Cultural stereotypes often suggest that women care less about their physical satisfaction than men. Past scientific studies provide mixed evidence on this topic. Some studies show that…

Novartis has launched three initiatives to close the healthcare gap in heart disease and cancer and is expanding its efforts with the goal of nearly tripling its footprint by 2030. The three initiatives include the new Inclusive Health Accelerator (IHA) program; IHA, which launched this week in five U.S. cities, aims to support early detection of prostate and breast cancer and address care disparities for underserved populations. Novartis uses a community-driven IHA model to support access to education, free testing, diagnosis, and follow-up care. Based in Basel, Novartis will offer the service in collaboration with local groups in New York,…

Sartorius announces the launch of CellCelector CLD, an automated imaging and cell separation platform designed to simplify and accelerate monoclonal cell line development (CLD) development. A combination of high-speed scanning, advanced imaging, and gentle clone searching allows scientists to quickly identify, validate, and isolate the most promising clones while preserving viability and ensuring reliable documentation. Image credit: Sartorius What used to take months can now be completed in about seven weeks. CellCelector CLD features full traceability at every step, giving teams the confidence to move from screening to stable, high-producing cell lines faster than standard workflows. ” Darius Wilson, CellCelector…